Aller au contenu principal
Profil bibliographique

Roger Kurlander

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

117Publications signalées
6266Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Hematopoietic Stem Cell TransplantationImmunotherapy and Immune ResponsesCAR-T cell therapy researchImmune Cell Function and InteractionT-cell and B-cell Immunology

Les publications récentes

Accès ouvert 2020 article OpenAlex

SR-BI mediates neutral lipid sorting from LDL to lipid droplets and facilitates their formation

Tatyana G. Vishnyakova, Alexander V. Bocharov, Irina N. Baranova, Roger Kurlander et autres

SR-BI binds various lipoproteins, including HDL, LDL as well as VLDL, and mediates selective cholesteryl ester (CE) uptake. HDL derived CE accumulates in cellular lipid droplets (LDs), which also store triacylglycerol (TAG). We hypothesized that SR-BI could significantly facilitate LD formation, in …

us (code pays fourni par la source)

5 citations PLoS ONE
Accès ouvert 2017 article OpenAlex

Heat shock proteins stimulate APOBEC-3–mediated cytidine deamination in the hepatitis B virus

Zhigang Chen, Thomas L. Eggerman, Alexander V. Bocharov, Irina N. Baranova et autres

Apolipoprotein B mRNA-editing enzyme catalytic subunit 3 (APOBEC-3) enzymes are cytidine deaminases that are broadly and constitutively expressed. They are often up-regulated during carcinogenesis and candidate genes for causing the major single-base substitution in cancer-associated DNA mutations. Moreover, APOBEC-3s are involved in …

us, au (code pays fourni par la source)

27 citations Journal of Biological Chemistry
2016 article OpenAlex

Excellent Outcomes of Combined Haploidentical and Cord-Blood (Haplo-Cord) Transplantation and HLA-Matched Sibling (Matched-Sib) Donor Transplantation for High-Risk Patients with Severe Aplastic Anemia (SAA) Refractory to Immunosuppressive Therapy

Enkhtsetseg Purev, Georg Aue, Phuong Vo, Ritesh R. Kotecha et autres

Abstract Introduction: Allogeneic hematopoietic stem cell transplantation (HSCT) is curative for SAA unresponsive to immunosuppressive therapy (IST). For SAA patients (pts) with a HLA-identical sibling donor, the use of peripheral-blood (PB) grafts have been reported to have increased risk of graft-versus-host disease …

us (code pays fourni par la source)

4 citations Blood
2016 article OpenAlex

A Naive NK Cell Repertoire in the Circulation of Haploidentical Stem Cell Donors Pre Mobilization Predicts Rejection of Cord Myeloid Cells in Patients Undergoing Combined Haploidentical and Unrelated Cord Blood HSCT

Mattias Carlsten, Robert Reger, Ritesh R. Kotecha, Enkhtsetseg Purev et autres

Abstract Background: For patients (pts) with severe aplastic anemia (SAA) lacking an HLA identical donor, outcomes of hematopoietic stem cell transplantation (HSCT) using unrelated cord blood (UCB) units or haplo-identical donors (HDs) have historically been associated with high graft failure rates and …

us (code pays fourni par la source)

0 citations Blood
Accès ouvert 2016 article OpenAlex

Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease

Jennifer N. Brudno, Robert Somerville, Victoria Shi, Jeremy J. Rose et autres

PURPOSE: Progressive malignancy is the leading cause of death after allogeneic hematopoietic stem-cell transplantation (alloHSCT). After alloHSCT, B-cell malignancies often are treated with unmanipulated donor lymphocyte infusions (DLIs) from the transplant donor. DLIs frequently are not effective at eradicating malignancy and often …

jp (code pays fourni par la source)

612 citations Journal of Clinical Oncology
Accès ouvert 2016 article OpenAlex

Clinical features predict responsiveness to imatinib in platelet-derived growth factor receptor-alpha-negative hypereosinophilic syndrome

Paneez Khoury, Ronan Desmond, Andrea Pabon, Nicole Holland‐Thomas et autres

BACKGROUND: With the exception of the presence of the FIP1L1-PDGFRA fusion gene, little is known about predictors of imatinib response in clinically-defined hypereosinophilic syndrome (HES). METHODS: Subjects with FIP1L1-PDGFRA-myeloid neoplasm (FP; n =12), PDGFRA-negative HES with ≥4 criteria suggestive of a myeloid …

us, ie (code pays fourni par la source)

54 citations Allergy
2015 article OpenAlex

Excellent Engraftment and Long-Term Survival in Patients with Severe Aplastic Anemia (SAA) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with Haplo-Identical CD34+ Cells Combined with a Single Umbilical Cord Blood Unit

Enkhtsetseg Purev, Georg Aue, Ritesh R. Kotecha, Jennifer Wilder et autres

Abstract For SAA patients (pts) lacking an HLA identical donor, outcomes of HSCT using single or dual unrelated cord blood (UCB) transplants or haplo-identical donors have been associated with high graft failure rates and poor survival. We investigated whether co-infusion of a …

us (code pays fourni par la source)

3 citations Blood
2015 article OpenAlex

Allogeneic T-Cells Expressing an Anti-CD19 Chimeric Antigen Receptor Cause Remissions of B-Cell Malignancies after Allogeneic Hematopoietic Stem Cell Transplantation without Causing Graft-Versus-Host Disease

Jennifer N. Brudno, Robert Somerville, Victoria Shi, Jeremy J. Rose et autres

Introduction Progressive malignancy is the leading cause of death after allogeneic hematopoietic stem cell transplantation (alloHSCT). After alloHSCT, B-cell malignancies are often treated with infusions of unmanipulated donor lymphocytes (DLIs) from the transplant donor. DLIs are frequently not effective at eradicating malignancy, …

us (code pays fourni par la source)

5 citations Blood
Accès ouvert 2015 article OpenAlex

Conditioning with rabbit versus horse ATG dramatically alters clinical outcomes in identical twins with severe aplastic anemia transplanted with the same allogeneic donor

Phuong Vo, Jeremy Pantin, Catalina Ramos, Lisa Cook et autres

Severe aplastic anemia (SAA) is a rare disorder leading to bone marrow failure, which if left untreated, is invariably fatal. Conventional therapies with immunosuppressive therapy or allogeneic hematopoietic stem cell transplantation (HSCT) are highly effective. HSCT can offer a greater outcome in …

us (code pays fourni par la source)

21 citations Journal of Hematology & Oncology
Accès ouvert 2015 article OpenAlex

High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor Responses

Miriam E. Mossoba, David Halverson, Roger Kurlander, Bazetta Blacklock Schuver et autres

PURPOSE: We hypothesized that lymphoid-selective host conditioning and subsequent adoptive transfer of sirolimus-resistant allogeneic T cells (T-Rapa), when combined with high-dose sirolimus drug therapy in vivo, would safely achieve antitumor effects while avoiding GVHD. EXPERIMENTAL DESIGN: Patients (n = 10) with metastatic …

us, it (code pays fourni par la source)

12 citations Clinical Cancer Research
Accès ouvert 2015 article OpenAlex

Pilot Clinical Trial of Lymphocyte-Selective Pentostatin Plus Cyclophosphamide Conditioning, High Dose Sirolimus and Pre-Emptive DLI with Rapamycin-Resistant Donor CD4+ T Cells

David Halverson, Miriam E. Mossoba, Brenna Hansen, Bazetta Blacklock Schuver et autres

We recently found that early pre-emptiveDLI with donor CD4+ T-Cells cultured in rapamycin (T-Rapa) allowed allo-engraftment after low-intensity fludarabine plus cyclophosphamide (Cy) host conditioning (Blood, 2013). To evaluate further reductions in conditioning intensity, we conducted a pilot clinical trial of allogeneic HSCT …

us (code pays fourni par la source)

0 citations Transplantation and Cellular Therapy

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.